Microglia in Alzheimer’s disease: Insights into disease progression and therapy
Advances in Immunology · 2026
DOI: 10.1016/bs.ai.2026.06.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Immunology, 2026. Verfasst von Vaishali Saini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease. Die Arbeit nennt 97 Literaturangaben. Gefördert von: Anusandhan National Research Foundation, Indian Institute of Technology Indore.
Themen: Demenz
Abstract (Originalsprache)
The role of microglia, once seen as bystanders, has recently shifted to that of central regulators in disease pathology. The shift has been observed in M1/M2-polarized microglia to multiple configurations, including disease-associated microglia (DAM), lipid-droplet-accumulating microglia (LDAM), senescent microglia, and interferon-responsive microglia. This chapter provides a comprehensive synthesis of microglial biology across multiple interfaces, including transcriptomic, lipid-associated metabolic, cell senescence, and metabolic reprogramming. Metabolic disharmony in microglia occurs when lipid dysregulation and inflammasome activation occurs, leading to chronic inflammation beyond the basic phagocytic repair function of microglia. The TREM2-associated therapeutic trajectory also shows a translational gap with mechanistic and clinical benefits. We also identify the need for critical disease-associated microglial biomarkers and intervention strategies. Moreover, advanced iPSC-derived microglia and chimeric models often yield specialized organoid co-cultures, accelerating microglia-mediated therapeutic studies. Collectively, this chapter entails microglia as a central player in AD. This positions microglia biology as a metabolically plastic, spatially organized immune-regulated microenvironment that can efficiently aid in reprogramming and AD therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, India.
- Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, India. Electronic address: hemcjha@iiti.ac.in.
Förderung
- Anusandhan National Research Foundation
- Indian Institute of Technology Indore
Zitieren
APA
Saini, V., Mukherjee, S., Vora, C., Jindal, H., & Jha, H. C. (2026). Microglia in Alzheimer’s disease: Insights into disease progression and therapy. Advances in Immunology. https://doi.org/10.1016/bs.ai.2026.06.004
Vancouver
Saini V, Mukherjee S, Vora C, Jindal H, Jha HC. Microglia in Alzheimer’s disease: Insights into disease progression and therapy. Advances in Immunology. 2026. doi:10.1016/bs.ai.2026.06.004
BibTeX
@article{Saini2026,
author = {Saini, Vaishali and Mukherjee, Srija and Vora, Chaitali and Jindal, Himanshi and Jha, Hem Chandra},
title = {Microglia in Alzheimer’s disease: Insights into disease progression and therapy},
journal = {Advances in Immunology},
year = {2026},
doi = {10.1016/bs.ai.2026.06.004}
}
EUVIMED